Treating Opioid Use Disorder: A Pharmacist's Guide to Understanding MAT
Starts at: September 19, 2020 9:00am ET
Ends at: September 19, 2020 1:00pm ET
Opioids use disorder (OUD) is a chronic condition that affects millions of Americans. If left untreated it can result in serious consequences including increased morbidity, relapse, opioid overdose, and death. Medication- assisted treatment is effective for OUD and has been shown to decrease all-cause mortality and opioid overdose-related deaths. This pharmacist-driven training will provide detailed education on the induction and maintenance of medication-assisted treatment for opioid use disorder.
Describe the epidemiology of opioid overdose and opioid use disorder in the United States
Examine the prescribing patterns of opioids for chronic non-cancer pain over the past two decades
Differentiate the clinical presentation of opioid dependence, opioid withdrawal and opioid use disorder
Classify the pharmacology and therapeutics for methadone, buprenorphine/naloxone, and naltrexone for the treatment of opioid use disorder
Discuss treatment considerations for patients with HIV and Opioid Use Disorder
Dr. Jasmine Carpenter, PharmD
Board-certified psychiatric pharmacist
Pharmacists and other healthcare professionals who will benefit from attending this program include: Physicians, Nurses, Social Workers, Medical Staff, Pharmacy Technicians as well Students pursuing healthcare disciplines.
The staff and faculty involved with the planning of today’s event do not have any conflicts of interest to disclose. The MidAtlantic AIDS Education and Training Center does not endorse or recommend any commercial products, processes, or services. The representations and opinions expressed in this presentation are solely those of the author(s) and do not represent the views or policies of MA AETC, the University of Pittsburgh, or its funding agencies.
The speakers have no conflicts of interest to disclose
A variety of the listed populations will be discussed at this event.
Young Adults (ages 18 to 24)
Older Adults (ages 50 and over)
American Indian or Alaska Native
Black or African American
Hispanic or Latino
A variety of the listed topics will be discussed at this event.
Harm Reduction/Safe Injection
U=U/treatment as prevention
Adult and adolescent antiretroviral treatment
Antiretroviral treatment adherence, including viral load suppression